Richard Stebbings

Statistics

Publications

Citations

1.9K

H-Index

Active since

1985

Affiliations

National Institute for Biological Standards and Control(Current)

AstraZeneca (United Kingdom)

National Institute of Standards and Technology

Melbourn Science Park

Center for Devices and Radiological Health

Richard Stebbings is an author at National Institute for Biological Standards and Control specializing in immunology, life sciences, and infectious diseases.

ORCID

Publications per year

1985–2022

Publications

“Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics

Richard Stebbings, Lucy Findlay, Cherry Edwards et al. · The Journal of Immunology · 2007 · 314 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 <sup>+</sup> effector memory T‐cells

David Eastwood, Lucy Findlay, Stephen Poole et al. · British Journal of Pharmacology · 2010 · 290 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Evasion of Cytotoxic T Lymphocyte (CTL) Responses by <i>Nef</i>-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells

Xiao-Ning Xu, Gavin Screaton, Frances Gotch et al. · The Journal of Experimental Medicine · 1997 · 192 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412

Lucy Findlay, David Eastwood, Richard Stebbings et al. · Journal of Immunological Methods · 2009 · 75 citations

Pharmacy, Pharmacology, Toxicology +13

After TGN1412: Recent developments in cytokine release assays

Richard Stebbings, David Eastwood, Stephen Poole et al. · Journal of Immunotoxicology · 2012 · 73 citations

Life Sciences, Immunology, Toxicology +17

1–5 of 36